Puma Biotechnology Earnings Call & Commercial Update 2023

Puma Biotechnology presented its earnings call and commercial update on May 4, 2023, focusing on the commercialization of NERLYNX and related drug candidates. The presentation outlines the company's pharmacy and distributor network strategy across academic hospitals, community hospitals, physician practices, and specialty pharmacy providers.